P6.15 * peroxiredoxin 3 as a molecular therapeutic target in breast cancer

Conclusion: Our data suggests that PRDX3 promotes breast tumorigenesis and could be a potential therapeutic target in breast cancer.

Source: Annals of Oncology - March 20, 2015 Category: Cancer & Oncology Authors: Chua, P. J., Chin, J., Chee, S., Thike, A. A., Yip, G., Tan, P. H., Bay, B. H. Tags: Poster session 6: New drugs/targets: other Source Type: research